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Highlights 
Reduced neurogenesis and intellectual disability characterize Down syndrome 
Fatty acids have been shown to be critical factors for proper neural development  
We found that corn oil restores neurogenesis in the Ts65Dn model of Down syndrome  
Corn oil improves hippocampus-dependent memory in the Ts65Dn model  
Supplementation with corn oil may represent a useful therapy for Down syndrome 
 
ABSTRACT 
Individuals with Down syndrome (DS), a genetic condition due to triplication of Chromosome 21, are 
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characterized by intellectual disability that worsens with age. Since impairment of neurogenesis and 
dendritic maturation are very likely key determinants of intellectual disability in DS, interventions targeted to 
these defects may translate into a behavioral benefit. While most of the neurogenesis enhancers tested so far 
in DS mouse models may pose some caveats due to possible side effects, substances naturally present in the 
human diet may be regarded as therapeutic tools with a high translational impact. Linoleic acid and oleic 
acid are major constituents of corn oil that positively affect neurogenesis and neuron maturation. Based on 
these premises, the goal of the current study was to establish whether treatment with corn oil improves 
hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn model of DS. Four-month-
old Ts65Dn and euploid mice were treated with saline or corn oil for 30 days. Evaluation of behavior at the 
end of treatment showed that Ts65Dn mice treated with corn oil underwent a large improvement in 
hippocampus-dependent learning and memory. Evaluation of neurogenesis and dendritogenesis showed that 
in treated Ts65Dn mice the number of new granule cells of the hippocampal dentate gyrus and their dendritic 
pattern became similar to those of euploid mice. In addition, treated Ts65Dn mice underwent an increase in 
body and brain weight. This study shows for the first time that fatty acids have a positive impact on the brain 
of the Ts65Dn mouse model of DS. These results suggest that a diet that is rich in fatty acids may exert 
beneficial effects on cognitive performance in individuals with DS without causing adverse effects. 
  
Key Words: Down syndrome; intellectual disability; Ts65Dn model; hippocampus; neurogenesis; dendrites; 
memory 
 
1. INTRODUCTION 
 
Triplication of Chromosome 21 causes Down syndrome (DS), a pathology characterized by brain 
hypotrophy and disability in several cognitive domains, including explicit memory. Since individuals with 
DS above 40 years of age are at high risk for the onset of Alzheimer’s disease, intellectual disability may 
transform into dementia (Hartley et al., 2015). Widespread impairment of neural precursor proliferation 
starting from fetal life stages is a key hallmark of DS (Haydar and Reeves, 2012; Stagni et al., 2017a). 
Moreover, the DS brain is characterized by severe impairment in dendritic maturation (Bartesaghi et al., 
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2011; Benavides-Piccione et al., 2004). Both these defects are thought to be key determinants of cognitive 
impairment in DS. No effective pharmacotherapies currently exist for intellectual disability in individuals 
with DS. Ideally, therapies to improve brain development should be performed at early life stages. Yet, since 
neurons of the hippocampal dentate gyrus are continuously generated throughout life, interventions that are 
able to improve hippocampal neurogenesis may also have a positive impact on hippocampus-dependent 
learning and memory at adult life stages and could possibly delay the onset of Alzheimer’s disease.  
 Among the various pharmacotherapies attempted in DS mouse models some of them proved to be 
effective in improving hippocampus-dependent learning and memory (Bartesaghi et al., 2011; Costa and 
Scott-McKean, 2013; Gardiner, 2015; Stagni et al., 2015). It should be noted, however, that some of the 
drugs used may also cause side effects, which diminishes their translational impact. For instance, lithium 
may impair renal function and inhibitors of GABAA receptors may have pro-convulsant effects. Ideally, the 
treatment of choice should be effective, safe and well tolerated. In this context, substances that are naturally 
present in the human diet should be regarded as therapeutic tools with a potentially strong translational 
impact.  
There is evidence that in addition to their role in metabolism, fatty acids can serve as signaling 
molecules by affecting intra- and extracellular receptor systems, either directly or after conversion to specific 
fatty acid derivatives (Georgiadi and Kersten, 2012). Poly- and/or mono-unsaturated fatty acids (PUFAs and 
MUFAs, respectively) have been implicated as critical nutritional factors for proper neural development and 
function (Gordon, 1997) and fatty acids appear to favor brain development and ameliorate cognitive 
functions in normal and diseased conditions (Hussain et al., 2013). Long chain poly-unsaturated fatty acids 
(LC-PUFAs), which make up 20% of the dry weight of the brain, are critical for healthy brain development 
and contribute to membrane structure and cytokine regulation. According to the position of the first double 
bond from the methyl end of the fatty acid chain, the most important PUFAs for humans can be divided into 
two families: n-6 (omega-6) and n-3 (omega-3) PUFAs. Linoleic acid (LA, 18:2n-6) is the parent fatty acid 
of omega-6 PUFAs, and produces principally arachidonic acid (AA, 20:4n-6), whereas α-linolenic acid 
(ALA, 18:3n-3) is the parent fatty acid of omega-3 PUFAs, and gives rise mainly to eicosapentaenoic acid 
(20:5n-3). LA and ALA must be supplied by food because they cannot be synthesized by the human body 
and for this reason they are called essential fatty acids. Essential fatty acids and their metabolites, especially 
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n-6 PUFA-derived mediators, have been shown to have profound effects on the proliferation of different 
stem cell types (Kang et al., 2014), including neural stem cells (Beltz et al., 2007; Maekawa et al., 2009; 
Sakayori et al., 2011; Tokuda et al., 2014). The observation that their deficiency alters neurogenesis (Coti 
Bertrand et al., 2006; Tang et al., 2016) highlights a possibly relevant role of n-6 PUFAs in the regulation of 
neurogenesis. The MUFA oleic acid (OA, C18:1n-9), which is the primary fatty acid in the white matter of 
the mammalian brain (O'Brien and Sampson, 1965), has been shown to promote axonogenesis in the striatum 
during brain development (Polo-Hernandez et al., 2010) and to favor dendritic differentiation (Rodriguez-
Rodriguez et al., 2004), suggesting a role of OA in neuron maturation. 
Corn oil, which is extracted from the germ of corn, contains a high percentage of both LA and OA. 
In view of the positive effects exerted by these fatty acids on neurogenesis and neuron maturation, the goal 
of the current study was to establish whether treatment with corn oil improves neurogenesis and neuron 
maturation in the hippocampal dentate gyrus of the Ts65Dn mouse model of DS and whether these effects 
are associated with a behavioral improvement.  
 
 
2. MATERIALS AND METHODS 
2.1. Colony 
In order to obtain Ts65Dn mice, B6EiC3Sn a/ATs(17<16>)65Dn females were mated with C57BL/6JEiJ x 
C3H/HeSnJ (B6EiC3Sn) F1 hybrid males provided by Jackson Laboratories (Bar Harbor, ME, USA). We 
used the first generation of this breeding. The genotyping of the animals was carried out as previously 
described (Reinholdt et al., 2011). The day of birth was designated postnatal day zero. The mice were kept in 
a room with a 12:12 h light/dark cycle and had free access to water and food. All efforts were made to 
minimize animal suffering and to keep the number of animals used to a minimum. 
2.2. Experimental protocol 
A total of 47 male mice aged 4 months were used. Mice were i.p. injected every other day for one month 
with i) saline (0.9% NaCl; n=17 euploid and n=8 Ts65Dn mice) or ii) corn oil (Sigma: C8267; 10 µl/g; n=12 
euploid and n=10 Ts65Dn mice). At the end of treatment, mice were behaviorally tested with the Morris 
Water Maze and Contextual Fear Conditioning tests. Because C3H/HeSnJ mice carry a recessive mutation 
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that leads to retinal degeneration (Rd), animals were genotyped by standard PCR to screen out mice carrying 
this gene. Mice that did not carry a recessive mutation that leads to retinal degeneration entered the 
behavioral study. At the end of behavioral testing mice were killed, the brain was removed, fixed by 
immersion in PFA 4% and frozen. Mice injected with saline will be called hereafter control mice and mice 
injected with corn oil will be called treated mice. 
2.3. Histological procedures 
The frozen hemispheres were cut with a freezing microtome into 30-m-thick coronal sections that were 
serially collected in anti-freezing solution (30% glycerol; 30% ethylen-glycol; 0.02% sodium azide; PBS1X 
to volume). 
2.4. Immunohistochemistry 
For doublecortin (DCX) immunohistochemistry, one out of six free-floating sections from the hippocampal 
formation (n=10 sections) were permealized with 0.4% Triton X-100 in KPBS and blocked for 2 h in 10% 
donkey serum in 0.4% Triton X-100 and KPBS. Sections were then incubated overnight at 4°C with a goat 
polyclonal anti-DCX antibody (Santa Cruz Biotechnology Cat# sc-8066, RRID: AB_2088494) diluted 1:100. 
Detection was performed with FITC-conjugated anti-goat secondary antibody (Abcam Cat# ab6881, RRID: 
AB_955236) diluted 1:200.  
2.5. Measurements 
2.5.1. Number of DCX-positive cells. Quantification of DCX-positive cells in the dentate gyrus was 
conducted in every 6th section using a fluorescence microscope (Nikon Eclipse TE 2000-S inverted 
microscope; Nikon Corp., Kawasaki, Japan; objective: x 20, 0.50 NA; final magnification: x 200), equipped 
with a Nikon digital camera DS 2MBWc. DCX-positive cells were counted along the whole length of the 
granule cell layer and their number was expressed as number of cells for 100 µm of linear length. 
2.5.2. Neuron sampling. Series of sections (n=10) across the dentate gyrus were used for reconstruction of 
the dendritic tree of DCX-positive neurons. DCX-positive neurons were sampled in the upper blade. Only 
neurons with branches extending beyond the outer one half of the molecular layer were selected. The total 
number of sampled neurons was 4-7 per animal.  
2.5.3. Measurement of the dendritic tree. The dendritic tree of DCX-positive cells was traced as previously 
described (Guidi et al., 2013). The operator starts with branches emerging from the cell soma and after 
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having drawn the first parent branch goes on with all daughter branches of the next order in a centrifugal 
direction. For each neuron, we evaluated total dendritic length, total number of branches, number of branches 
of each order and mean branch length.  
2.6 Behavioral testing 
2.6.1. Morris Water Maze (MWM). The MWM test was used in order to examine hippocampus-dependent 
learning and memory. Mice were maintained in a room with reverse light/dark cycle. Animals were tested 
starting at 08.30-09.00am and before being tested were put in the behavior room for 1 h of habituation. Mice 
were trained in the MWM task to locate a hidden escape platform in a circular pool. The apparatus consisted 
of a large circular water tank (1.00 m diameter, 50 cm height) with a transparent round escape platform (10 
cm2). The pool was virtually divided into four equal quadrants identified as Northeast, Northwest, Southeast, 
and Southwest. The pool was filled with tap water at a temperature of 20-22ºC up to 0.5 cm above the top of 
the platform and the water was made opaque with milk. The platform was placed in the pool in a fixed 
position (in the middle of the Southwest quadrant). The pool was placed in a large room with intra- (squares, 
triangles, circles and stars) and extra-maze visual cues. A video camera was placed above the center of the 
pool and connected to a videotracking system (ANY-maze Behavioral tracking software 5.0, Wheat Lane 
Wood Dale, IL, U.S.A.). The MWM test was organized as follows. Days 1-8: learning sessions; day 9: probe 
test. During the learning phase mice were subjected to 4 trials on day one and to two blocks of 4 trials 
separated by an interval of 45 minutes on days 2-8. Mice were released facing the wall of the pool randomly 
from the North, East, South, or West starting point and allowed to search for up to 60 s for the platform. If 
they reached the platform within this time they were left on the platform for 15 s, then they were returned to 
the home cage and tested again after 10 s. If mice did not reach the platform they were gently put on the 
platform, left there for 15 s and then returned to the home cage and tested again after 10 s. For the learning 
phase, we evaluated the latency to find the hidden platform, time in the periphery of the water tank 
(thigmotactic behavior), percentage of time in the periphery, path length, proximity to the platform, and 
swimming speed. Retention was assessed with one trial (probe trial), on the ninth day, 24 h after the last 
acquisition trial, using the same starting point for all mice. During this trial, the platform was removed from 
the tank. Mice were allowed to search for up to 60 s for the platform. For the probe trial, the latency of the 
first entrance in the trained platform zone, the frequency of entrances in the trained quadrant, the proximity 
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to the trained platform position (Gallagher’s test), the percentage of time spent at the periphery 
(thigmotaxis), the swimming speed and the percentage of time spent in each quadrant were evaluated. All 
experimental sessions were carried out between 8.30am and 5.00pm.  
2.6.2. Contextual Fear Conditioning (CFC). CFC was performed the day after the MWM. The test occurred 
in 30 x 24 x 21 cm operant chambers (Ugo Basile, Comerio VA, Italy). Each chamber was equipped with a 
stainless-steel rod floor through which a footshock could be administered, two stimulus lights, one house 
light, and a solenoid, all controlled by ANY-maze computer software (Behavioral tracking software 5.0, 
Wheat Lane Wood Dale, IL, U.S.A.). The chambers were located in a sound-isolated enclosure in the 
presence of red light. Mice were trained and tested on 2 consecutive days (Comery et al., 2005). The training 
procedure consisted of placing a subject in a chamber and allowing exploration for 2 min. An auditory cue 
[74 dB, 2000 Hz clicking via the solenoid; conditioned stimulus (CS)] was presented for 15 s. A 2 s 
footshock [0.6 mAmp; unconditioned stimulus (US)] was administered for the final 2 s of the CS. The entire 
procedure was repeated three times and mice were removed from the chamber 30 s later. Twenty hours after 
training, mice were returned to the same chamber in which training occurred (context), and freezing behavior 
was recorded by the experimenter using time sampling (10 s intervals). Freezing was defined as lack of 
movement except that required for respiration. At the end of the 5 min context test, mice were returned to 
their home cage. Approximately 1 h later, freezing was recorded in a novel environment and in response to 
the cue. The novel environment consisted of modifications including an opaque Plexiglas divider diagonally 
bisecting the chamber, a Plexiglas floor, and decreased illumination. Mice were placed in the novel 
environment, and time sampling was used to score freezing for 3 min. The auditory cue (CS) was then 
presented for 3 min, and freezing was again scored. All phases of the test were recorded and immobility was 
detected by using the video tracking and analysis software ANY-maze (Behavioral tracking software 5.0, 
Wheat Lane Wood Dale, IL, U.S.A.). Freezing scores for each subject were expressed as a percentage for 
each portion of the test. Memory for the context (contextual memory) for each subject was obtained by 
subtracting the freezing percentage in the novel environment from that in the context. 
2.7 Cultures of subventricular zone neural progenitor cells (NPCs) 
Cells were isolated from the subventricular zone (SVZ) of newborn (age: 1-2 days) euploid and Ts65Dn 
mice. Briefly, brains were removed, SVZ regions were isolated and individually collected in ice-cold PIPES 
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buffer pH 7.4. After centrifugation, tissue was digested for 10 min at 37°C using Trypsin/EDTA 0.25% (Life 
Technologies) aided by gentle mechanical dissociation. Cell suspension from each individual mouse was 
plated onto 25 cm2 cell-culture flask (Thermo Fisher Scientific) and cultured as floating neurospheres in 
medium containing basic fibroblast growth factor (bFGF, 10 ng/ml; Peprotech) and epidermal growth factor 
(EGF, 20 ng/ml; Peprotech) using an established protocol (Meneghini et al., 2014). Primary (Passage 1, P1) 
neurospheres were dissociated using StemproAccutase (Life Technologies) after 7 days in vitro (DIV), 
thereafter neurospheres were passaged every 5 DIV. For proliferation studies, neurospheres (P3-P12) were 
dissociated in a single cell suspension and plated onto NunclonTM Delta Surface 96-well plate (Thermo 
Fisher Scientific) at a density of 4×103 cells per well in DMEM/F-12 medium supplemented with B27, 
GlutamaxTM, heparin sodium salt (4 μg/ml; ACROS Organics), bFGF (10 ng/ml), and 100 U/100 μg/ml 
Penicillin/Streptomycin (Life Technologies). NPC cultures were treated for 96 h with LA-BSA complex 
(0.1-100 µM, Sigma-Aldrich), OA-BSA complex (0.1-100 µM, Sigma-Aldrich) and corresponding vehicle 
(BSA 3.3 mg/ml, Sigma-Aldrich). For antagonistic experiments, cells were treated with LA-BSA complex 
(100 M) in presence of either GSK0660, a PPAR/ antagonist (0.1-10 µM, MCE), GW9662, a PPAR 
antagonist (0.01-30 µM, MCE) and corresponding vehicle (DMSO 0.05 %- BSA 3.3 mg/ml). Lithium 
chloride (LiCl, 2mM, Sigma-Aldrich) was used as positive control (Trazzi et al., 2014). Cell proliferation 
was quantified as relative luminescence units (RLU) values using CellTiter-Glo viability assay reagent 
(Promega) on a Victor3-V plate reader (PerkinElmer). 
2.8 Statistical analysis 
Results are presented as mean ± standard error of the mean (SE). Data were analyzed with IBM SPSS 22.0 
software. Before running statistical analyses, we checked data distribution and homogeneity of variances for 
each variable using the Shapiro-Wilk test and Levene’s test respectively. Since the in vitro data were not 
normally distributed, statistical analysis was carried out using Kruskal-Wallis test followed by Mann–
Whitney U test for comparisons between different doses of either LA or OA and vehicle, between LiCl and 
vehicle and different concentrations of the PPAR/ or the PPAR antagonist and vehicle. A comparison 
between LA, OA, and LiCl was also carried out. Statistical analysis of the in vivo data was carried out using 
a two-way ANOVA with genotype (euploid, Ts65Dn) and treatment (saline, corn oil) as factors. Post hoc 
multiple comparisons were carried out using the Fisher Least Signiﬁcant Difference (LSD) test. For the 
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learning phase of MWM, statistical testing was performed using a three-way mixed ANOVA, with genotype 
and treatment as grouping factors and days as a repeated measure. For the probe test, save for the percentage 
of time spent in quadrants, we used a two-way ANOVA with genotype and treatment as factors followed by 
the Fisher LSD post hoc test. For the time spent in quadrants, we compared the percentage of time spent in 
the Northwest, Southeast, and Northeast quadrants with the percentage of time spent in the trained platform 
quadrant (Southwest) using a paired-sample t-test. Based on the “Box plot” tool available in SPSS 
Descriptive Statistics we excluded from each analysis the extremes, i.e. values that were larger than 3 times 
the IQ range [x ≥ Q3 + 3 * (IQ); x ≤ Q1 – 3 * (IQ)]. A probability level of p ≤ 0.05 was considered to be 
statistically significant.  
 
3. RESULTS 
 
3.1. Effect of corn oil on body and brain weight 
A two-way ANOVA on body weight before treatment showed no genotype x treatment interaction, a 
significant main effects of genotype [F(1,43) = 12.25, p = 0.001] but no main effect of treatment. Before 
treatment, there was no body weight difference between Ts65Dn mice destined to be treated with vehicle and 
those destined to be treated with corn oil (Fig. 1A). Both groups had a reduced body weight in comparison 
with euploid mice destined to be treated with vehicle (Fig. 1A). A two-way ANOVA on body weight after 
treatment showed a genotype x treatment interaction [F(1,43) = 4.21, p = 0.046], a main effects of genotype 
[F(1,43) = 12.59, p = 0.001] and a main effect of treatment [F(1,43) = 4.27, p = 0.045]. At the end of 
treatment, treated Ts65Dn mice had a body weight larger than control Ts65Dn mice and similar to that of 
control euploid mice (Fig. 1B). In euploid mice, treatment had no effect on body weight (Fig. 1B). 
A two-way ANOVA on brain weight showed no genotype x treatment interaction and no main effect 
of genotype or treatment. Treatment with corn oil had no effect on the brain weight of either Ts65Dn or 
euploid mice in comparison with their control counterparts (Fig. 1C). Treated Ts65Dn mice, however, 
AC
CE
PT
ED
 M
AN
US
CR
IPT
10 
 
exhibited a significant increase in brain weight in comparison with treated euploid mice (Fig. 1C).  
 
3.2. Effect of corn oil on learning and memory in Ts65Dn and euploid mice 
MWM test is classically used in mouse models of DS to assess hippocampus-dependent learning and 
memory. For the learning phase, the following variables were evaluated: escape latency, time in periphery, 
percentage of time in periphery, path length, proximity. We additionally evaluated the swimming speed. We 
carried out a three-way mixed ANOVA for all variables followed by the post hoc Fisher LSD test. Results of 
ANOVA are reported hereafter and results of the post hoc test are summarized in Table 1. 
A three-way mixed ANOVA on escape latency, with genotype and treatment as grouping factors and 
day as a repeated measure revealed no effect of genotype x treatment x day. We found a genotype x day 
interaction [F(7,301) = 5.64, p < 0.001], a genotype x treatment interaction [F(1,43) = 10.30, p = 0.003], no 
treatment x day interaction, a main effect of genotype [F(1,43) = 40.65, p < 0.001], a main effect of treatment 
[F(1,43) = 5.49, p = 0.024], and a main effect of day [F(7,301) = 45.62, p < 0.001]. While control euploid 
mice exhibited a fast learning improvement with time, in control Ts65Dn mice the latency to reach the 
platform did not decrease as the test progressed, indicating poor learning capacity (Fig. 2A, Table 1). In 
contrast, Ts65Dn mice treated with corn oil showed a large learning improvement in comparison with their 
control counterparts, although their escape latency did not attain the values of control euploid mice (Fig. 2A, 
Table 1). In euploid mice treated with corn oil the latency was similar to that of control euploid mice (Fig. 
2A; Table 1).  
A three-way mixed ANOVA on the absolute time spent in the periphery zone (thigmotaxis), with 
genotype and treatment as grouping factors and day as a repeated measure revealed no effect of genotype x 
treatment x day. We found a genotype x day interaction [F(7,301) = 4.27, p < 0.001], a genotype x treatment 
interaction [F(1,43) = 10.01, p = 0.003], but no treatment x day interaction; a main effect of genotype 
[F(1,43) = 21.35, p < 0.001] was also found, as was a main effect of day [F(7,301) = 60.27, p < 0.001], while 
there was no main effect of treatment. A post hoc Fisher LSD test showed that, while control Ts65Dn mice 
spent more time in the periphery zone than control euploid mice, Ts65Dn mice treated with corn oil spent a 
similar time there as control euploid mice, save for days 4 and 7 (Fig. 2B, Table 1), suggesting an 
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improvement in searching strategy. Euploid mice treated with corn oil showed no changes in thigmotaxis. 
A three-way mixed ANOVA on the percentage of time spent in the periphery zone, with genotype 
and treatment as grouping factors and day as a repeated measure, revealed no effect of genotype x treatment 
x day. We found a genotype x day interaction [F(7,301) = 2.17, p = 0.037], while neither a treatment x day 
interaction nor a genotype x treatment interaction were present. There was a main effect of genotype [F(1,43) 
= 19.93, p < 0.001], no main effect of treatment; but a main effect of day [F(7,301) = 17.84, p < 0.001]. A 
post hoc Fisher LSD test showed that the time that control Ts65Dn mice spent in the periphery zone, 
expressed as a percentage of the total latency, was larger than that of control euploid mice (Fig. 2C, Table 1). 
In treated Ts65Dn mice the percentage of time in thigmotaxis underwent a reduction and on days 5-8 it was 
significantly reduced in comparison with their control counterparts (Fig. 2C, Table 1), suggesting an 
improvement in spatial learning. 
A three-way mixed ANOVA on path length, with genotype and treatment as grouping factors and 
day as a repeated measure revealed no effect of genotype x treatment x day. We found a genotype x day 
interaction [F(7,301) = 8.90, p < 0.001], while there was no treatment x day interaction, or genotype x 
treatment interaction. A main effect of genotype [F(1,43) = 14.59, p < 0.001] was observed, while no main 
effect of treatment emerged. A main effect of day [F(7,301) = 47.16, p < 0.001] was present. In all groups, 
the path length decreased from day 4 to day 8 (Fig. 2D). A post hoc Fisher LSD test showed no differences 
in the path length between control and treated Ts65Dn mice or between control and treated euploid mice 
(Table 1).  
A three-way mixed ANOVA on proximity to the trained platform position (Gallagher’s test; 
proximity), with genotype and treatment as grouping factors and day as a repeated measure revealed no 
effect of genotype x treatment x day. We found a genotype x day interaction [F(7,301) = 3.78, p = 0.001], a 
treatment x day interaction [F(7,301) = 4.27, p < 0.001], no genotype x treatment, a main effect of genotype 
[F(1,43) = 18.85, p < 0.001], no main effect of treatment, but a main effect of day [F(7,301) = 23.58, p < 
0.001]. Fig. 2E shows that, while in control euploid mice the distance from the platform position decreased 
from day 1 to day 8, control Ts65Dn mice underwent no improvement. In contrast, treated Ts65Dn mice 
underwent an improvement and on days 7-8 their distance from the platform was significantly reduced in 
comparison with their control counterparts; on days 5-8 their distance was similar to that of control euploid 
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mice (Fig. 2E, Table 1).  
A two-way ANOVA on the mean swimming speed during the 8 days of the learning phase, with 
genotype and treatment as grouping factors showed a genotype x treatment interaction [F(1,43) = 9.43, p = 
0.004], a main effect of genotype [F(1,43) = 4.96, p = 0.031], and a main effect of treatment [F(1,43) = 6.22, 
p = 0.017]. A post hoc Fisher LSD test showed that in control Ts65Dn mice the swimming speed was 
reduced in comparison with control euploid mice. This difference disappeared in treated Ts65Dn mice (Fig. 
2F).  
In the probe test, we considered the following parameters as an index of spatial memory: i) latency to 
enter the trained platform zone (latency); ii) frequency of entrances into the trained quadrant (frequency); iii) 
proximity to the trained platform position (Gallagher’s test; proximity); iv) percentage of time spent in the 
periphery zone (thigmotaxis); v) percentage of time spent in each quadrant. We additionally evaluated the 
swimming speed. A two-way ANOVA on the latency showed no genotype x treatment interaction, no main 
effect of genotype, and no main effect of treatment. A post hoc Fisher LSD test showed no significant 
differences between groups, although treated Ts65Dn mice underwent a latency reduction in comparison 
with their control counterparts (Fig. 3A). A two-way ANOVA on the frequency showed no genotype x 
treatment interaction, a main effect of genotype [F(1,43) = 4.55, p = 0.039] but no main effect of treatment. 
A post hoc Fisher LSD test showed that control Ts65Dn mice exhibited a reduced frequency of entrances in 
comparison with control euploid mice. In treated Ts65Dn mice there was an increase in the frequency that 
became similar to that of control euploid mice (Fig. 3B). A two-way ANOVA on the proximity showed no 
genotype x treatment interaction, while there was a main effect of genotype [F(1,43) = 18.37, p < 0.001] and 
a main effect of treatment [F(1,43) = 11.45, p = 0.002]. A post hoc Fisher LSD test showed that control 
Ts65Dn mice swam at a greater distance from the trained platform zone in comparison with control euploid 
mice (Fig. 3C). Treated Ts65Dn mice swam closer to the trained platform zone and their performance 
became similar to that of control euploid mice (Fig. 3C).  
A two-way ANOVA on the percentage of time spent in the periphery zone showed no genotype x 
treatment interaction, no main effect of genotype, and no main effect of treatment. A post hoc Fisher LSD 
test showed that in control Ts65Dn mice the percentage of time spent in the periphery zone was greater than 
that of control euploid mice (Fig. 3D). In treated Ts65Dn mice the percentage of time spent in the periphery 
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zone was reduced in comparison with their control counterparts (Fig. 3D), suggesting restoration of the 
searching strategy. 
A two-way ANOVA on the swimming speed showed no genotype x treatment interaction. A main 
effect of genotype [F(1,43) = 6.34, p = 0.016] was found, but there was no main effect of treatment. A post 
hoc Fisher LSD test showed that in control Ts65Dn mice swimming speed was reduced in comparison with 
control euploid mice. This difference disappeared in treated Ts65Dn mice (Fig. 3E). 
A paired samples t-test showed that control Ts65Dn mice exhibited no differences in the time spent 
in the trained platform quadrant (SW) in comparison with the other quadrants (Fig. 3F). Treated Ts65Dn 
mice spent more time in the trained platform quadrant and in the Northwest (NW) quadrant, although these 
differences were not statistically significant. Control euploid mice spent marginally more time in the trained 
platform quadrant in comparison with the Northeast (NE) quadrant [t(16) = 2.07, p = 0.054] and the 
Southeast (SE) quadrant [t(16) = 2.06, p = 0.056] (Fig. 3F). Treated euploid mice spent significantly more 
time in the trained platform quadrant in comparison with the SE [t(11) = 2.33, p = 0.040] and NE [t(11) = 
3.38, p = 0.006] quadrants (Fig. 3F).  
The CFC paradigm is a test that allows for estimation of both hippocampus-independent (cued) and 
hippocampus-dependent (contextual) memory (McHugh et al., 2007). A two-way ANOVA with genotype 
and treatment as grouping factors on the performance in the old context showed an interaction between 
genotype and treatment [F(1,41) = 5.42, p = 0.025] and no main effect of either genotype or treatment. A 
post hoc Fisher LSD test showed that control Ts56Dn mice showed a lower freezing behavior in the trained 
environment (old context) compared to euploid control mice (Fig. 4A), although the difference was not 
significant (p = 0.075). In treated Ts65Dn mice the freezing behavior significantly increased in comparison 
with their control counterparts (Fig. 4A), indicating improvement of memory for the context. No effect of 
treatment was found in euploid mice (Fig. 4A). A two-way ANOVA with genotype and treatment as factors 
on the performance in the cued session showed no interaction between genotype and treatment, no main 
effect of treatment but a main effect of genotype [F(1,43) = 5.57, p = 0.023]. A post hoc Fisher LSD test 
showed no difference between groups save for treated Ts65Dn mice that had a reduced freezing in 
comparison with control euploid mice (Fig. 4B). Freezing in the cued session is expressed as difference 
between the percentage of freezing during the sound (cue) delivery and the spontaneous freezing in the new 
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context. We considered of interest to establish possible differences between groups in the amount of freezing 
in the new context and during sound delivery, respectively. Fig. 4C shows that in the new context both 
treated euploid and Ts65Dn mice exhibited a higher freezing in comparison with their control counterparts, 
although the difference was not statistically significant. During sound delivery, while control Ts65Dn mice 
exhibited a lower freezing in comparison with euploid mice, this difference disappeared in treated Ts65Dn 
mice (Fig. 4D).  
 
3.3. Effect of corn oil on hippocampal neurogenesis in Ts65Dn and euploid mice 
 Doublecortin (DCX) is a microtubule-associated phosphoprotein selectively located in the periphery 
of the soma with a pattern that overlaps microtubule distribution (Couillard-Despres et al., 2005). DCX is 
expressed in the cytoplasm of immature granule neurons during the period of neurite elongation (from one to 
four weeks after neuron birth), which allows evaluation of total number of new granule cells. In order to 
establish whether treatment with corn oil enhances neurogenesis in the hippocampal dentate gyrus, brain 
sections were subjected to immunohistochemistry for DCX. In agreement with the morphogenesis of the 
granule cell layer, DCX-positive cells were located in the innermost portion of the layer, close to the hilus 
(Fig. 5A). A two-way ANOVA on the number of DCX-positive cells showed no genotype x treatment 
interaction but a main effect of genotype [F(1,14) = 29.39, p < 0.001] and treatment [F(1,14) = 10.30, p = 
0.006]. In agreement with previous evidence, control Ts65Dn mice had a reduced number of new granule 
cells in comparison with their euploid counterparts (Fig. 5A,B). In Ts65Dn mice treated with corn oil there 
was an increase in the number of new neurons in comparison with control Ts65Dn mice (Fig. 5A,B) that 
became similar to that of control euploid mice (Fig. 5A,B). In euploid mice treatment with corn oil did not 
affect the number of new granule cells (Fig. 5A,B). These results suggest that treatment with corn oil exerts a 
beneficial effect on hippocampal neurogenesis specifically in Ts65Dn mice. 
 
3.4. Effect of corn oil on dendritic development in Ts65Dn and euploid mice 
Dendritic morphology of newborn granule cells was analyzed in sections subjected to 
immunohistochemistry for DCX. Fig 6A shows examples of the dendritic pattern in each experimental 
group. It can be readily appreciated that the granule cells of control Ts65Dn mice had a poorly-branched 
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dendritic tree and that treatment with corn oil increased its complexity.  
A two-way ANOVA on the total length of the dendritic tree showed no genotype x treatment 
interaction, no main effect of genotype, but a main effect of treatment [F(1,14) = 12.54, p = 0.003]. A post 
hoc Fisher LSD test showed that in control Ts65Dn mice the dendritic length was reduced in comparison 
with control euploid mice and that treatment with corn oil fully restored total dendritic length (Fig. 6B). A 
two-way ANOVA on the total number of dendritic branches showed no genotype x treatment interaction and 
no main effect of genotype and treatment. A post hoc Fisher LSD test showed no differences between 
groups, although in treated Ts65Dn mice the total number of branches was marginally larger (p = 0.06) in 
comparison with their control counterparts (Fig. 6C). The analysis of the number of branches of each order 
showed no interaction between genotype x treatment and no main effect of genotype and treatment for all 
orders, save for order 5 that showed a main effect of treatment [F(1,14) = 4.89, p = 0.044]. A post hoc Fisher 
LSD test showed no differences between groups for orders 1-3 and 6-7 (Fig. 6E). However, control Ts65Dn 
mice had a reduced number of branches of order 5 in comparison with control euploid mice and treated 
Ts65Dn mice had a larger number of branches of order 4 and 5 in comparison with control Ts65Dn mice 
(Fig. 6E). Importantly, while control Ts65Dn mice lacked branches of orders 6 and 7, in treated Ts65Dn 
mice branches of orders 6 and 7 were also present (Fig. 6E). A two-way ANOVA on the mean branch length 
showed no genotype x treatment interaction no main effect of genotype and no main effect of treatment. A 
post hoc Fisher LSD test showed no differences between groups (Fig. 6D). 
 
3.5. Effect of linoleic acid and oleic acid on the proliferation rate of neural progenitor cells from Ts65Dn 
and euploid mice 
Corn oil contains a high percentage (~54%) of PUFAs, mainly represented by LA (omega-6), and a 
high percentage (~28%) of the MUFA OA (omega-9). In order to investigate whether the most abundant 
PUFA and MUFA in corn oil could directly affect neurogenesis, we used cultures of neural progenitor cells 
(NPCs) from the subventricular zone of Ts65Dn mice. Cultures were exposed to different concentrations of 
LA or OA (from 0.1 to 100.0 µM). The Kruskal-Wallis test showed a significant effect of LA on 
proliferation rate [χ2 (8) = 44.43, p < 0.001]. The Mann-Whitney test showed that in cultures exposed to LA 
there was a proliferation increase in comparison with cultures exposed to vehicle at concentrations of 60.0 
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µM (U = 0.001, p = 0.007), 80 µM (U = 0.001, p = 0.007), and 100 µM (U = 0.001, p < 0.001) (Fig. 6A). 
The Kruskal-Wallis test showed a significant effect of OA on proliferation rate [χ2 (8) = 48.84, p < 0.001]. 
The Mann-Whitney test showed that in cultures exposed to OA there was a proliferation increase in 
comparison with cultures exposed to vehicle at concentrations of 80 µM (U = 0.001, p = 0.006), and 100 µM 
(U = 0.001, p < 0.001) (Fig. 6B).  
A comparison of the pro-proliferative effect of different concentrations of LA showed that the effect 
of the concentration of 60 µM was lower in comparison with the concentration of 80 µM (U = 0.000, p = 
0.050) and 100 µM (U = 6.000, p = 0.044), and that there were no differences between the concentrations of 
80 µM and 100 µM (Fig. 7A). A comparison of the pro-proliferative effect of different concentrations of OA 
showed that the concentration of 80 µM had an effect that was lower in comparison with the concentration of 
100 µM (U = 2.000, p = 0.011) (Fig. 7B). A comparison of the effects of LA and OA showed that the 
proliferation increase caused by LA was larger than that caused OA (U = 68.000; p = 0.003) (Fig. 7C). While 
LA at a concentration of 100 µM caused a 45% increase in proliferation rate in comparison with cultures 
exposed to vehicle, OA at a concentration of 100 µM caused a 26 % increase only. This evidence indicates 
that LA is a more powerful neurogenesis enhancer in comparison with OA. 
Since lithium has been shown to restore proliferation of NPCs of Ts65Dn mice in vivo (Bianchi et 
al., 2010; Contestabile et al., 2013) and in vitro (Trazzi et al., 2014), it seemed of interest to compare the pro-
proliferative effect of lithium and those of LA/OA. We used a 2.0 mM concentration of LiCl based on 
previous evidence showing that this concentration restores neurogenesis in trisomic NPCs (Trazzi et al., 
2014). As expected, LiCl increased the proliferation of trisomic cells (+ 34 %) compared to vehicle (Fig. 
7C). Since LA and OA were effective at 100 µM, they appear to be more potent enhancers of NPCs 
proliferation than LiCl.  
We exposed euploid cultures of NPCs from the subventricular zone of euploid mice to LA and OA in 
order to establish their effects on euploid cells. The Kruskal-Wallis test showed a significant effect of LA on 
proliferation rate [χ2 (8) = 43.07, p < 0.001]. The Mann-Whitney test showed that in cultures exposed to LA 
there was a proliferation increase in comparison with cultures exposed to vehicle at the concentration of 100 
µM (U = 0.000, p < 0.001) (Fig. 7D). The Kruskal-Wallis test showed a significant effect of OA on 
proliferation rate [χ2 (8) = 40.71, p < 0.001]. The Mann-Whitney test showed that in cultures exposed to OA 
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there was a proliferation increase in comparison with cultures exposed to vehicle at concentrations of 80 µM 
(U = 0.000, p = 0.001), and 100 µM (U = 8.000, p < 0.001) (Fig. 7E). In euploid cultures exposed to LiCl 
there was an increase in proliferation (+ 41 %) compared to vehicle (Fig. 7F). 
 
3.6. The pro-proliferative effect of linoleic acid are blocked by PPAR and PPAR antagonists 
The mechanisms of action of PUFAs on neurogenesis remain elusive (Dyall, 2015), although there 
are suggestions of a possible role of peroxisome-proliferator activated receptors (PPARs) (Bernal et al., 
2015). PPARs are a group of transcription factors that represent the best recognized nuclear sensor system 
for fatty acids (Fidaleo et al., 2014; Georgiadi and Kersten, 2012). There are three isotypes of PPARs, named 
PPARα, PPARβ/δ and PPAR (Fidaleo et al., 2014). Mouse NPCs express isotypes PPARβ/δ and PPAR 
only (Bernal et al., 2015). In order to investigate whether the pro-proliferative effect exerted by the most 
abundant corn oil PUFA, LA, could be mediated by PPARs, trisomic cells were exposed to LA 100 µM in 
presence of either a PPAR / antagonist (GSK0660, 0.1-30 M) or a PPAR antagonist (GW9662, 0.01-10 
M). The Kruskal-Wallis test showed a significant effect of the PPAR / antagonist [χ2 (5) = 19.86, p = 
0.001] and the PPAR  antagonist [χ2 (4) = 33.57, p < 0.001] on proliferation. We found that both antagonists 
counteracted the LA-induced proliferative effects on trisomic NPCs (Fig. 8A,B). Exposure to the PPARβ/δ 
receptor antagonist GSK0660 caused a moderate reduction in the pro-proliferative effect of LA at all tested 
concentrations (0.1-30 µm), but did not completely abrogate its effect, even at the highest concentration (Fig. 
8A). Exposure to the PPAR receptor antagonist GW9662 at low concentrations (0.01 µm) did not reduce 
the pro-proliferative effect of LA (Fig. 8B). However, exposure to higher concentrations (1, 3, and 10 µm) 
reduced and even abrogated the effect of LA (Fig. 8B). Taken together, these results suggested that, at least 
in vitro, PPAR/and PPAR contribute to the proliferative effects of LA on trisomic NPC.  
 
4. DISCUSSION 
 
4.1. Corn oil positively impacts on hippocampal neurogenesis in Ts65Dn mice 
While neurogenesis is a process that is largely accomplished before birth, in the hippocampal dentate 
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gyrus neurogenesis persists throughout life in all examined mammals, including humans (Bayer, 1980; 
Eriksson et al., 1998; Guidi et al., 2011; Guidi et al., 2004; Kempermann and Gage, 2002; Ninkovic et al., 
2007; Spalding et al., 2013). Hippocampal neurogenesis has been shown to be severely impaired in fetuses 
with DS and in mouse models of DS at early life stages (Stagni et al., 2017a) and in adulthood (Belichenko 
and Kleschevnikov, 2011; Clark et al., 2006; Lorenzi and Reeves, 2006; Rueda et al., 2005). A number of 
studies has explored the effects of different drugs on hippocampal neurogenesis and hippocampus-dependent 
learning and memory in mouse models of DS (Gardiner, 2015; Stagni et al., 2015). In the current study, we 
found that treatment with a natural substance, corn oil, leads to restoration of neurogenesis in the 
hippocampus of adult Ts65Dn mice, which demonstrates for the first time that corn oil can enhance 
neurogenesis in DS.  
While it is known that LA and OA increase cognitive performance (Jenkins et al., 2016; Moazedi et 
al., 2007), little evidence is available regarding the pro-neurogenic role of these fatty acids. By exploiting 
cultures of NPCs, we found that both LA and OA are able to increase the proliferation rate of NPCs, which 
suggests that both fatty acids of corn oil may potentially contribute to the neurogenesis increase observed in 
Ts65Dn mice treated with corn oil. The effects of LA, however, were larger than those of OA and had a 
magnitude that was comparable to that exerted by lithium, indicating that LA may act as a potent 
neurogenesis enhancer in the trisomic brain. Our in vitro results indicate that PPARand PPAR are 
involved in the direct effects of LA on NPCs suggesting that these receptors may contribute to the beneficial 
effects elicited by corn oil in trisomic mice. There is evidence that the triplicated gene Down syndrome 
critical region 2 (DSCR2) physically interacts with PPARβ in mammalian HEK293 cells and inhibits its 
ligand-induced transcriptional activity (Song et al., 2008). This suggests that this inhibition may contribute to 
impair neurogenesis in the DS brain and strengthens the conclusion that the positive effect of corn oil in 
Ts65Dn mice may be mediated by PPARs. Of course, other mechanisms and contributors cannot be ruled 
out.  
 
4.2. Corn oil positively impacts on dendritic development in Ts65Dn mice 
In Ts65Dn mice, newborn granule cells had a reduced total dendritic length. This confirms previous 
evidence that dendritic hypotrophy starts at the initial stages of granule cells development (Guidi et al., 2013) 
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and is in agreement with evidence of severe dendritic pathology in the Ts65Dn model of DS as well as in 
individuals with DS (Benavides-Piccione et al., 2004; Dang et al., 2014; Guidi et al., 2013). The reduction in 
total dendritic length was due to a reduction in the number of branches of intermediate order and a lack of 
high order branches, and not to a reduction in the mean branch length. In Ts65Dn mice treated with corn oil 
there was an increase in the number of branches of intermediate order and the de novo appearance of high 
order branches, with consequent restoration of total dendritic length. Neuron generation and dendritic 
maturation are severely compromised in DS. Thus, therapies to improve brain development should be aimed 
at restoring both of these processes. Current results show that corn oil restores the dendritic length of 
trisomic granule cells, indicating that the same treatment is able to restore not only the number of new 
granule neurons but also their "quality", in terms of correct maturation.  
 
4.3. Corn oil positively impacts on hippocampus-dependent learning and memory in Ts65Dn mice 
The deficits in hippocampus-dependent learning and memory in DS are attributable to reduced 
neurogenesis and synaptic alterations in the hippocampal formation, a region that is fundamental for 
declarative memory. We found that the restoration of neurogenesis and dendritic pattern of new granule 
neurons induced by treatment with corn oil in Ts65Dn mice was accompanied by a large improvement in 
hippocampus-dependent learning and memory as assessed with the MWM test. During the learning phase, 
the reduction in the latency to reach the platform and in the time spent in the periphery showed that a large 
improvement had taken place; the proximity to the trained platform quadrant was similar to that of control 
euploid mice, indicating restoration of this parameter. In the probe test, the frequency of entrances in the 
trained platform quadrant, the proximity and the time spent in the periphery, became similar to that of control 
euploid mice, indicating restoration of these aspects of memory. It must be noted that control Ts65Dn mice 
had a slightly lower swimming speed in comparison with control euploid mice (-13%). It may be argued that 
the longer latency to reach the platform exhibited by control Ts65Dn mice in comparison with euploid mice 
during the learning phase of the MWM was due to their reduced speed, and that the latency reduction in 
treated Ts65Dn mice was due to the treatment-induced improvement in swimming speed and not to a 
learning improvement. However, on day 5 of the learning phase control Ts65Dn mice had a latency that was 
3 times that of euploid mice, while their speed was only reduced by 13%, suggesting that the longer latency 
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of Ts65Dn mice mainly reflects impairment of learning rather than a motor deficit. On day 5, the latency of 
treated Ts65Dn mice decreased by 40% in comparison with their control counterparts while swimming speed 
only increased by 15%, suggesting that the latency reduction was mainly due to an improvement in spatial 
learning and not in swimming speed. Moreover, the finding that treated Ts65Dn mice spent less time in the 
periphery and swam closer to the platform quadrant during the learning phase, and crossed the trained 
platform quadrant with increased frequency in the probe test, indicates an improvement in the searching 
strategy and, thus, in spatial learning.  
Conflicting results are available regarding the swimming speed of Ts65Dn mice. While some reports 
show no swimming speed differences in comparison with euploid mice (Catuara-Solarz et al., 2015; Costa et 
al., 2010; Escorihuela et al., 1995; Faizi et al., 2011; Netzer et al., 2010; Stagni et al., 2017b), other studies 
show that Ts65Dn mice have a reduced speed (Catuara-Solarz et al., 2016; Costa et al., 1999; Heinen et al., 
2012). These discrepancies may be accounted for by differences in the sex and/or age of mice and/or by the 
notably higher degree of variability in swimming speed that characterizes Ts65Dn mice (Costa et al., 1999).  
The CFC test showed that in treated Ts65Dn mice freezing in the old context increased in 
comparison with their control counterparts, suggesting improvement of context memory. During the cued 
session, however, treated Ts65Dn mice showed reduced freezing in comparison with control mice, which 
may suggest a poor association between the sound (cue) and the adverse stimulus (foot shock). Observation 
of Fig. 4D, however, shows that treated Ts65Dn mice demonstrated similar freezing to control euploid mice 
during sound delivery, suggesting no impairment in the retention of the association between sound and 
shock. On the other hand, treated Ts65Dn mice exhibited a higher (although not significant) level of freezing 
in the new context in comparison with control mice (Fig. 4C). Since freezing in the cued session is expressed 
as the difference between freezing during sound delivery and freezing in the new context, the reduced 
freezing of treated Ts65Dn in comparison with control mice during the cued session (Fig. 4B) may be due to 
a higher level of freezing in the new context rather than to an impairment in cue association learning.  
Taken together, the current results are in agreement with a number of studies showing that Ts65Dn 
mice are impaired in learning and memory. In treated Ts65Dn mice, the parameters of the learning phase and 
probe test ameliorated in comparison with their control counterparts and some of the examined parameters 
became similar to those of control euploid mice. Moreover, the CFC test showed that treated Ts65Dn mice 
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remembered the context to a similar extent as did control euploid mice. The finding that treatment with corn 
oil largely improved or even restored hippocampus-dependent learning and memory is consistent with our 
finding that treatment restored hippocampal neurogenesis and dendritogenesis. The fact that treatment did 
not fully restore behavior may be related to the relatively low rate of neurogenesis at the examined age and, 
thus, to the relatively low number of new granule neurons added to the hippocampal circuits in comparison 
with pre-existing neurons.  
 
4.4. Corn oil restores body weight in Ts65Dn mice 
We found that after treatment with corn oil the body weight of Ts65Dn mice became similar to that 
of euploid mice. This effect is in agreement with evidence that in pre-term infants treated with PUFAs there 
is an improvement in growth and developmental scores (Fleith and Clandinin, 2005). To our knowledge, this 
is the first demonstration that it is possible to restore the reduced body weight of Ts65Dn mice through 
administration of corn oil. The effect of corn oil may be related to an improvement in metabolic processes 
exerted by fatty acids as well as to an increase in caloric intake. The finding that treatment increased the 
swimming speed of Ts65Dn mice suggests that corn oil may exert beneficial effects on the trophism of 
muscle cells.  
We found no differences in the brain weight of five-month-old Ts65Dn mice compared to euploid 
mice, in contrast with our findings in younger mice (Stagni et al., 2017b). While treatment with corn oil had 
no effect in euploid mice, Ts65Dn mice underwent a small but significant brain weight increase. Since most 
of the brain neurons are born prenatally, the increase in brain weight may be related to an improvement in 
the composition of the neuronal membranes and/or growth of the neuronal processes.  
 
4.5 Treatment with corn oil does not affect neurogenesis and cognitive performance in euploid mice 
 Unlike in Ts65Dn mice, treatment with corn oil did not increase proliferation and dendritic 
maturation of granule cells in the hippocampal dentate gyrus of euploid mice and did not enhance 
hippocampus-dependent learning and memory. Yet, exposure to LA or OA was able to increase the 
proliferation rate of euploid NPCs in vitro, indicating that euploid NPCs are responsive to LA and OA 
similarly to trisomic NPCs. Taken together these results suggest that the lack of effects of corn oil in vivo in 
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euploid mice may be due to a ceiling effect that prevents further enhancement of hippocampal development. 
This is consistent with previous observations that treatments that are effective in Ts65Dn mice may not have 
a similar efficacy in euploid mice (Corrales et al., 2014; Dang et al., 2014; Stagni et al., 2017b). 
 
4.6. Conclusions 
Nourishment with PUFAs and MUFAs has been shown to have a positive effect in various types of 
neurological disorders (Hussain et al., 2013). LA is the major PUFA, and OA is the major MUFA, of corn 
oil. Unlike OA, LA cannot be synthesized by the human body, so it must be exogenously supplied (Hussain 
et al., 2013). Arachidonic acid, which is a derivative of LA, has been shown to increase neurogenesis at 
postnatal stages when administered prenatally (Maekawa et al., 2009). Decreased levels of OA have been 
observed in the brain of Alzheimer’s disease patients (Martin et al., 2010) and OA supplementation has been 
shown to inhibit the production of Aβ peptide and amyloid plaques (Amtul et al., 2011).  
We found here that corn oil restores neurogenesis and improves hippocampus-dependent memory in 
adult Ts65Dn mice. Treatments that ameliorate hippocampal neurogenesis in adulthood may increase the 
"cognitive reserve" and postpone the onset of Alzheimer’s-due dementia (Whalley et al., 2004). Although we 
administered corn oil intraperitoneally, our data may suggest that a diet based on an appropriate fatty acid 
intake may exert a benefit on cognitive performance in individuals with DS. It is conceivable that treatment 
with fatty acids during the critical windows of neurogenesis (prenatal and early postnatal period) may have 
larger effects than those observed here and may possibly lead to a full behavioral rescue.  
Various studies have explored the effects of a variety of pharmacological agents on hippocampus-
dependent learning and memory in adult Ts65Dn mice (see (Gardiner, 2015)). Treatments i) targeted to 
transmitter/receptor systems, ii) employing neuroprotective agents, antioxidants, and free radical scavengers, 
iii) targeted to perturbed signaling pathways, iv) aimed at normalizing the expression of proteins coded by 
triplicated genes and v) that have used proneurogenic molecules demonstrated that it is possible to 
pharmacologically rescue or partially rescue behavioral deficits. While most of these studies show that it is 
possible to improve cognitive performance in a model of DS, some of the used therapies pose some caveats 
for human application in view of the nature of the used molecules that may potentially cause side effects. 
Corn oil, which is extracted from the germ of corn, contains a high percentage of fatty acids which are 
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substances that are naturally present in the human diet. The current study shows that adult treatment with 
corn oil restores neurogenesis, dendritic development, and learning and memory in the Ts65Dn model of DS. 
Thus, supplementation of fatty acids may represent a promising and safe therapy for DS with a good 
translational potential in adulthood as well as at early life stages. 
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FIGURE LEGENDS 
 
Fig. 1. Effect of treatment with corn oil on the body and brain weight. 
A-C: Body weight before treatment (A) and body (B) and brain (C) weight after treatment (mean  SE) in 
grams of control euploid mice (n=17), control Ts65Dn mice (n=8), treated euploid mice (n=12) and treated 
Ts65Dn mice (n=10). * p < 0.05; ** p < 0.01; *** p < 0.001 (Fisher LSD test after two-way ANOVA). 
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Abbreviation: CO, corn oil; Eu, euploid; Sal, saline. 
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Fig. 2. Effect of treatment with corn oil on spatial learning in Ts65Dn and euploid mice. 
Control euploid mice (n=17), control Ts65Dn mice (n=8), treated euploid mice (n=12) and treated Ts65Dn 
mice (n=10) were subjected to the MWM starting from the first day after treatment cessation (i.e. at 5 
months of age). A-E: Learning phase of the MWM evaluated as latency to reach the platform (A), time spent 
at the periphery (thigmotaxis) (B), percentage of time spent at the periphery (C), path length (D), and 
proximity to the platform zone (E). F: Mean swimming speed of the four experimental groups obtained by 
averaging the speed of individual trials during the whole 8 day-period of the learning phase. Results of the 
post hoc Fisher LSD test are reported in Table 1. B-D: Values represent mean  SE. Abbreviations: cm, 
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centimeters; CO, Corn oil; Eu, euploid; m, meters; Sal, saline; sec, seconds. 
 
 
Fig. 3. Effect of treatment with corn oil on spatial memory in Ts65Dn and euploid mice. 
Spatial memory was assessed in the probe test after spatial learning in control euploid mice (n=17), control 
Ts65Dn mice (n=8), treated euploid mice (n=12) and treated Ts65Dn mice (n=10). Mice are the same as in 
Fig. 2. In the probe test, memory was assessed as latency to reach the trained platform zone (A), number of 
crossings (frequency) over the trained platform quadrant (B), proximity to the trained platform zone (C), 
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percentage of time spent at the periphery (D), percentage of time spent in quadrants (F). E: Swimming speed 
during the probe test. Values represent mean  SE. * p < 0.05; ** p < 0.01; *** p < 0.001 (Fisher LSD test 
after two-way ANOVA). The symbol § in (F) indicates a difference between each individual quadrant and 
the trained platform quadrant (see key on the left) for each experimental group. (§) p < 0.06; § p < 0.05; §§ p 
< 0.01 (two-sample paired t-test). Abbreviations: cm, centimeters; CO, Corn oil; Eu, euploid; NE, north-east; 
NW, north-west; Sal, saline; sec, seconds; SE, south-east, SW, south-west. 
 
Fig. 4. Effect of treatment with corn oil on contextual fear conditioning in Ts65Dn and euploid mice. 
Control euploid mice (n=17), control Ts65Dn mice (n=8), treated euploid mice (n=12) and treated Ts65Dn 
mice (n=10) were subjected to the CFC test. Based on exclusion criteria (see Methods) we excluded from the 
analysis of the old context session 1 control euploid mouse (yielding 16 mice) and 1 control Ts65Dn mouse 
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(yielding 7 mice). A-D: Percentage of freezing in the old context (A), in the cued session (B), in the new 
environment of the cued session (C) and in the cued session during sound delivery (D). * p < 0.05; ** p < 
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0.01 (Fisher LSD test after two-way ANOVA). Abbreviations: CO, Corn oil; Eu, euploid; Sal, saline. 
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Fig. 5. Effect of treatment with corn oil on the number of new granule cells in the dentate gyrus.  
The number of new granule cells was evaluated with DCX immunohistochemistry. A: Examples of sections 
processed for fluorescent immunostaining for DCX from the dentate gyrus of control euploid and Ts65Dn 
mice and euploid and Ts65Dn mice treated with corn oil. Calibration bar = 20 µm. B: Number of DCX-
positive cells in the dentate gyrus of control euploid (n=5) and Ts65Dn (n=5) mice, corn oil treated euploid 
(n=4) and Ts65Dn (n=4) mice. Values represent mean  SE. ** p < 0.01; *** p < 0.001 (Fisher LSD test 
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after two-way ANOVA).. Abbreviations: CO, Corn oil; Eu, euploid; Sal, saline. 
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Fig. 6. Effect of corn oil on the dendritic size of newborn granule cells.  
 A: Two examples (a, b) of the reconstructed dendritic tree of DCX-positive granule cells from animals of 
each of the following experimental groups: control euploid (n=5) and Ts65Dn (n=5) mice and treated 
euploid (n=4) and Ts65Dn (n=4) mice. Numbers indicate the different dendritic orders. Calibration bar = 50 
m. B-E: Total dendritic length (B), mean number of dendritic segments (C), mean segment length (D) and 
mean number of branches of the different orders (E) in control euploid and Ts65Dn mice, and euploid and 
Ts65Dn mice treated with corn oil. The arrows in (E) indicate the absence of branches of order 6 and 7 in 
control Ts65Dn mice. Values in (B-E) represent mean  ES. (*) p < 0.06; * p < 0.05; ** p < 0.01 (Fisher 
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LSD test after two-way ANOVA). Abbreviations: CO, Corn oil; Eu, euploid; Sal, saline. 
 
Fig. 7. Effect of treatment with oleic acid and linoleic acid on cultures of neural progenitor cells.  
Neural progenitor cells from the subventricular zone of neonate (age: 1-2 days) Ts65Dn and euploid mice 
were maintained for 96 h in a vehicle composed of 10 ng/ml bFGF and BSA 3.3 mg/ml or in vehicle 
supplemented with either LA or OA, at the indicated concentrations (0.1-100 µM). Parallel cultures were 
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maintained in a vehicle composed of 10 ng/ml bFGF and 0.05% DMSO or supplemented with LiCl 2.0 mM. 
A-C: A proliferation assay in Ts65Dn cultures showed a pro-proliferative effect of LA (A) and OA (B) in 
comparison with cultures exposed to vehicle and that the pro-proliferative effects of LA and OA were 
comparable to those exerted by LiCl (C). D-F: A proliferation assay in euploid cultures showed a pro-
proliferative effect of LA (D) and OA (E) in comparison with cultures exposed to vehicle and that the pro-
proliferative effects of LA and OA were comparable to those exerted by LiCl (F). Data in A-C were obtained 
in pooled cultures from Ts65Dn mice (n=2). Data in D-F were obtained in pooled cultures from euploid mice 
(n=2). Values (mean  SE) are expressed as fold change over the vehicle condition. ** p < 0.01; *** p < 
0.001 (Mann-Whitney test after Kruskal-Wallis test). Abbreviations: LA, linoleic acid; LiCl, Lithium 
chloride; OA, oleic acid, Veh, vehicle.  
 
 
Fig. 8. Effect of PPAR and PPAR antagonists on linoleic acid-mediated effects.  
Neural progenitor cells from the subventricular zone of neonate (age: 1-2 days) Ts65Dn mice were 
maintained for 96 h either in a vehicle composed of 10 ng/ml bFGF and 0.05% DMSO or in vehicle 
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supplemented with LA 100 µM alone or LA 100 µM plus either the PPARantagonist GSK0660 (A) or 
the PPAR antagonist GW9662 (B) at the indicated concentrations (µM). Data were obtained in pooled 
cultures from Ts65Dn mice (n=3). Values (mean  SE) are expressed as fold change over the vehicle 
condition. * p < 0.05; ** p < 0.01; *** p < 0.001 vs. LA; ## p < 0.01; ### p < 0.001 vs. vehicle (Mann-
Whitney test after Kruskal-Wallis test). Abbreviation: LA, linoleic acid; Veh, vehicle. 
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Table 1. P values of the Fisher LSD test for the indicated variables. 
  Escape Latency Time Periphery (sec)  Time Periphery (%) 
  D1 D2 D3 D4 D5 D6 D7 D8 D1 D2 D3 D4 D5 D6 D7 D8 D1 D2 D3 D4 D5 D6 D7 D8 
Eu+Sal Ts+Sal .208 .004 <.001 <.001 <.001 <.001 <.001 <.001 .035 <.001 <.001 <.001 <.001 .002 <.001 <.001 .040 <.001 .021 .002 .017 <.001 <.001 .012 
  Eu+CO .226 .976 .783 .568 .291 .809 .438 .575 .203 .426 .923 .197 .161 .654 .676 .796 .371 .694 .878 .631 .541 .604 .814 .483 
  Ts+CO .321 .159 .027 .007 .002 .032 .022 .028 .099 .019 .108 .027 .685 .660 .029 .437 .165 .001 .177 .009 .897 .035 .037 .810 
Eu+CO Ts+Sal .853 .006 <.001 <.001 <.001 <.001 <.001 <.001 .331 .002 .001 .002 .014 .008 <.001 .001 .221 .001 .022 .011 .075 .001 <.001 .004 
  Ts+CO .883 .181 .065 .038 .039 .028 .136 .113 .669 .125 .157 .336 .386 .988 .091 .619 .606 .005 .165 .040 .676 .125 .033 .401 
Ts+Sal Ts+CO .755 .123 .017 .002 .012 .001 .005 .001 .580 .097 .031 .028 .002 .011 <.001 .007 .472 .407 .320 .524 .038 .041 .004 .035 
  Path Lenght Proximity         
  D1 D2 D3 D4 D5 D6 D7 D8 D1 D2 D3 D4 D5 D6 D7 D8         
Eu+Sal Ts+Sal .014 .762 0.057 .016 <.001 .110 <.001 0.709 .020 .002 .010 .002 .017 .001 <.001 <.001         
  Eu+CO .323 .427 .832 .308 .460 .854 .992 .145 .241 .014 .549 .553 .535 .416 .150 .686         
  Ts+CO .666 .355 .121 .076 <.001 <.001 <.001 .037 .086 .011 .159 .022 .175 .052 .243 .120         
Eu+CO Ts+Sal .002 .708 .105 .138 .004 .175 <.001 .121 .203 .299 .004 .013 .077 <.001 <.001 <.001         
  Ts+CO .205 .870 .206 .436 <.001 <.001 <.001 .002 .559 .834 .069 .099 .467 .013 .021 .073         
Ts+Sal Ts+CO .058 .612 .668 .461 .069 .038 .866 .150 .480 .417 .227 .342 .287 .155 .011 .022         
 
 
Abbreviations: D, day; Eu, euploid; CO, corn oil; Sal, saline; sec, seconds; Ts, Ts65Dn.  
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